Management of Worsening Heart Failure With Reduced Ejection Fraction - Université de Lorraine
Article Dans Une Revue Journal of the American College of Cardiology Année : 2023

Management of Worsening Heart Failure With Reduced Ejection Fraction

Résumé

Despite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population. Herein, we propose a framework for treating worsening HF with reduced ejection fraction with the sense of urgency it deserves. This includes treating congestion; managing precipitants; and establishing a foundation of rapid-sequence, simultaneous, and/or in-hospital initiation of quadruple medical therapy for HF with reduced ejection fraction, with the top priority being at least low doses of all 4 medications. Moreover, to maximally reduce residual clinical risk, we further propose consideration of upfront simultaneous use of vericiguat (ie, quintuple medical therapy) and administration of intravenous iron for those who are iron deficient. (
Fichier principal
Vignette du fichier
1-s2.0-S0735109723058746-main.pdf (330.52 Ko) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04176512 , version 1 (03-08-2023)

Licence

Identifiants

Citer

Stephen J Greene, Johann Bauersachs, Jasper J Brugts, Justin A Ezekowitz, Gerasimos Filippatos, et al.. Management of Worsening Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology, 2023, 82 (6), pp.559-571. ⟨10.1016/j.jacc.2023.04.057⟩. ⟨hal-04176512⟩
22 Consultations
90 Téléchargements

Altmetric

Partager

More